This article is more than 5 years old. Information may no longer be current.
Two academic centers for excellence receive anticoagulation care research grants
Click Here to Manage Email Alerts
The first Anticoagulation Call to Action Initiative research grants from Boehringer Ingelheim Pharmaceuticals, Inc. were awarded to the University of California-Davis and the University of Miami Miller School of Medicine, according to a news release.
Academic centers for excellence in atrial fibrillation (AF) and stroke were challenged to both identify unmet needs and address areas of interest in anticoagulation care research through this Anticoagulation Call to Action (ACT) Initiative pilot program.
Of 125 academic institutions invited to participate, five finalists made to the live presentation and question-and-answer session and the final two were selected by an independent external review committee of leaders in AF and stroke, according to the release.
Committee members considered innovative approach and focus on addressing knowledge gaps in anticoagulation care, including treatment and management.
“It was exciting, both scientifically and operationally, to see projects that can help identify atrial fibrillation patients who need anticoagulation in novel ways — involving a genetic risk score and electronic health record alerts,” Christopher Cannon, MD, executive director of cardiometabolic trials, Harvard Clinical Research Institute, and committee member said in the release.
The project presented by Glen Jickling, MD, on behalf of University of California-Davis, will evaluate whether a gene marker can improve identification of AF in patients with ischemic stroke. Seemant Chaturvedi, MD, presented a project for the University of Miami Miller School of Medicine that will assess the impact of a computerized electronic alert program to improve stroke prevention treatment.
“It was also wonderful to see how this approach could generate novel ideas from so many clinician scientists from around the country — and actually fund the work in less than 2 months from the initial call for proposals,” Cannon said.
The selected proposals were reviewed for consideration to receive up to $500,000 in research funding. The research programs are expected to be implemented and their outcomes presented within one year of receiving the grant.